ArticlePloS one2015
Modeling and Analyzing the Transmission Dynamics of HBV Epidemic in Xinjiang, China.
Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 68 citations in OpenAlex.
- Simulation and prediction of human brucellosis epidemic trends in Changji city.Infectious Disease Modelling · 2026Article
- Seasonal dynamic modeling for real-time prediction of human brucellosis epidemiological trends in Gansu, Guangdong and Sichuan Provinces, China.PLoS neglected tropical diseases · 2026Article
- Development and evaluation of a machine learning model predicting out-of-hospital cardiac arrest using environmental factors.NPJ digital medicine · 2025Article
- Impacts of optimal control strategies on the HBV and COVID-19 co-epidemic spreading dynamics.Scientific reports · 2024Article
- Modelling the dynamics of acute and chronic hepatitis B with optimal control.Scientific reports · 2023Article
- Modelling of Hepatitis B Virus vertical transmission dynamics in Ethiopia: a compartmental modelling approach.BMC infectious diseases · 2023Article
- Mathematical model analysis of effective intervention strategies on transmission dynamics of hepatitis B virus.Scientific reports · 2023Article
- Article
- Analysis of HBV and COVID-19 Coinfection Model with Intervention Strategies.Computational and mathematical methods in medicine · 2023Article
- Impact of information intervention on stochastic hepatitis B model and its variable-order fractional network.The European physical journal. Special topics · 2022Article
- Disease burden of chronic hepatitis B and complications in China from 2006 to 2050: an individual-based modeling study.Virology journal · 2020Article
- The prevention and control of tuberculosis: an analysis based on a tuberculosis dynamic model derived from the cases of Americans.BMC public health · 2020Article
- Time Prediction Models for Echinococcosis Based on Gray System Theory and Epidemic Dynamics.International journal of environmental research and public health · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV) which affects livers. In this paper, we formulate a hepatitis B model to study the transmission dynamics of hepatitis B in Xinjiang, China. The epidemic model involves an exponential birth rate and vertical transmission. For a better understanding of HBV transmission dynamics, we analyze the dynamic behavior of the model. The modified reproductive number σ is obtained. When σ < 1, the disease-free equilibrium is locally asymptotically stable, when σ > 1, the disease-free equilibrium is unstable and the disease is uniformly persistent. In the simulation, parameters are chosen to fit public data in Xinjiang. The simulation indicates that the cumulated HBV infection number in Xinjiang will attain about 600,000 cases unless there are stronger or more effective control measures by the end of 2017. Sensitive analysis results show that enhancing the vaccination rate for newborns in Xinjiang is very effective to stop the transmission of HBV. Hence, we recommend that all infants in Xinjiang receive the hepatitis B vaccine as soon as possible after birth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.